Featured Research

from universities, journals, and other organizations

Team approach may be helpful for integrating genetic testing in management of retinoblastoma

Date:
November 14, 2011
Source:
JAMA and Archives Journals
Summary:
Integrating genetic testing into the management of retinoblastoma by using a multidisciplinary team approach is associated with more timely evaluation of patients and ensuring that all members of the patient's health-care team are aware of genetic implications with regard to cancer risk, according to a new report.

Integrating genetic testing into the management of retinoblastoma by using a multidisciplinary team approach is associated with more timely evaluation of patients and ensuring that all members of the patient's health care team are aware of genetic implications with regard to cancer risk, according to a report in the November issue of Archives of Ophthalmology, one of the JAMA/Archives journals.

Related Articles


"Retinoblastoma is a rare malignant tumor of the developing retina, with an incidence of one case in 16,000 to 18,000 live births," the authors write as background information in the article. Mutation of the RB1 gene has been linked to some cases of retinoblastoma, and genetic testing of the RB1 gene has increased as techniques to analyze the gene have improved. "The primary rationale for genetic testing in retinoblastoma is to aid in determining the risk of subsequent cancers (both subsequent retinoblastoma and other primary neoplasia) in the affected child and the risk of retinoblastoma in other family members, e.g., siblings and offspring."

Shweta U. Dhar, M.D., M.S., of Baylor College of Medicine, Houston, Texas, and colleagues describe outcomes associated with a comprehensive approach to provide genetic testing and counseling for patients with retinoblastoma using a multidisciplinary team of pediatric oncologists, ophthalmologists, a geneticist, and genetic counselors. The study included data collected over an eight-year period (January 2001 to December 2008) from patients diagnosed with retinoblastoma at Texas Children's Hospital.

The authors retrospectively evaluated data on 90 cases during the study period; 81 patients who were diagnosed with retinoblastoma, and nine children who were evaluated because of family history of retinoblastoma. Of the 81 patients with retinoblastoma, 34 (42 percent) had bilateral tumors (tumors in both eyes) and 47 (58 percent) had unilateral tumors (tumor in only one eye).

Genetic testing was accomplished in 51 (63 percent) of 81 patients with retinoblastoma using a multidisciplinary approach. Twenty-two patients (65 percent) in the bilateral group and 29 patients (62 percent) in the unilateral group underwent genetic testing. The ability to identify a genetic mutation in the blood sample of patients with bilateral retinoblastoma was 91 percent (20 of 22 patients). Of the 29 patients undergoing genetic testing in the unilateral group, five (17 percent) had a mutation identified in blood samples, documenting a hereditary form of retinoblastoma. In another seven patients (23 percent) mutation analysis confirmed the occurrence of sporadic retinoblastoma.

Overall, genetic testing of 48 at-risk family members from 21 families revealed six individuals positive and 42 negative for the familial mutation of the RB1 gene. Thus, performing genetic testing of retinoblastoma patients followed by testing their at-risk family members may eliminate the need for additional testing in the majority of relatives and identify the few high-risk relatives who need intensive screening.

"In conclusion, this study has demonstrated that a multidisciplinary approach has a significant effect on the management of retinoblastoma," the authors write. "Our study emphasizes that genetics can be incorporated into the management plan of all retinoblastoma patients using a team approach to ensure timely evaluations and appropriate counseling. Genetic evaluations improved risk prediction for patients and family members as well as prevented overutilization of clinical screening tests, which had potential morbidity for relatives documented to not carry an RB1 mutation."


Story Source:

The above story is based on materials provided by JAMA and Archives Journals. Note: Materials may be edited for content and length.


Journal Reference:

  1. S. U. Dhar, M. Chintagumpala, C. Noll, P. Chevez-Barrios, E. A. Paysse, S. E. Plon. Outcomes of Integrating Genetics in Management of Patients With Retinoblastoma. Archives of Ophthalmology, 2011; 129 (11): 1428 DOI: 10.1001/archophthalmol.2011.292

Cite This Page:

JAMA and Archives Journals. "Team approach may be helpful for integrating genetic testing in management of retinoblastoma." ScienceDaily. ScienceDaily, 14 November 2011. <www.sciencedaily.com/releases/2011/11/111114174003.htm>.
JAMA and Archives Journals. (2011, November 14). Team approach may be helpful for integrating genetic testing in management of retinoblastoma. ScienceDaily. Retrieved November 28, 2014 from www.sciencedaily.com/releases/2011/11/111114174003.htm
JAMA and Archives Journals. "Team approach may be helpful for integrating genetic testing in management of retinoblastoma." ScienceDaily. www.sciencedaily.com/releases/2011/11/111114174003.htm (accessed November 28, 2014).

Share This


More From ScienceDaily



More Health & Medicine News

Friday, November 28, 2014

Featured Research

from universities, journals, and other organizations


Featured Videos

from AP, Reuters, AFP, and other news services

Ebola Leaves Orphans Alone in Sierra Leone

Ebola Leaves Orphans Alone in Sierra Leone

AFP (Nov. 27, 2014) — The Ebola epidemic sweeping Sierra Leone is having a profound effect on the country's children, many of whom have been left without any family members to support them. Duration: 01:02 Video provided by AFP
Powered by NewsLook.com
Experimental Ebola Vaccine Shows Promise In Human Trial

Experimental Ebola Vaccine Shows Promise In Human Trial

Newsy (Nov. 27, 2014) — A recent test of a prototype Ebola vaccine generated an immune response to the disease in subjects. Video provided by Newsy
Powered by NewsLook.com
Pet Dogs to Be Used in Anti-Ageing Trial

Pet Dogs to Be Used in Anti-Ageing Trial

Reuters - Innovations Video Online (Nov. 26, 2014) — Researchers in the United States are preparing to discover whether a drug commonly used in human organ transplants can extend the lifespan and health quality of pet dogs. Video provided by Reuters
Powered by NewsLook.com
Today's Prostheses Are More Capable Than Ever

Today's Prostheses Are More Capable Than Ever

Newsy (Nov. 26, 2014) — Advances in prosthetics are making replacement body parts stronger and more lifelike than they’ve ever been. Video provided by Newsy
Powered by NewsLook.com

Search ScienceDaily

Number of stories in archives: 140,361

Find with keyword(s):
 
Enter a keyword or phrase to search ScienceDaily for related topics and research stories.

Save/Print:
Share:  

Breaking News:

Strange & Offbeat Stories

 

Health & Medicine

Mind & Brain

Living & Well

In Other News

... from NewsDaily.com

Science News

Health News

Environment News

Technology News



Save/Print:
Share:  

Free Subscriptions


Get the latest science news with ScienceDaily's free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

Get Social & Mobile


Keep up to date with the latest news from ScienceDaily via social networks and mobile apps:

Have Feedback?


Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?
Mobile iPhone Android Web
Follow Facebook Twitter Google+
Subscribe RSS Feeds Email Newsletters
Latest Headlines Health & Medicine Mind & Brain Space & Time Matter & Energy Computers & Math Plants & Animals Earth & Climate Fossils & Ruins